BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, July 7, 2026
Home » Authors » John Fox

Articles by John Fox

Preeclampsia outcomes improved in mouse models

May 24, 2017
By John Fox
A new Japanese study’s findings cast light on the role of intracellular signaling mediated by reactive oxygen species (ROS) in maintaining placental angiogenesis, which may explain the failure of clinical trials of antioxidants in preeclampsia and supports their use for the currently untreatable condition.
Read More

Preeclampsia outcomes improved in mouse models

May 19, 2017
By John Fox
A new Japanese study's findings cast light on the role of intracellular signaling mediated by reactive oxygen species (ROS) in maintaining placental angiogenesis, which may explain the failure of clinical trials of antioxidants in preeclampsia and supports their use for the currently untreatable condition.
Read More

First antibody directly targeting Ras oncogenes is now developed

May 17, 2017
By John Fox
The first therapeutic monoclonal antibody (MAb) that selectively targets activated intracellular cytosolic Ras mutant proteins, which are inaccessible to current antibodies, has been developed and assessed preclinically in a new South Korean study.
Read More

First antibody directly targeting Ras oncogenes is now developed

May 16, 2017
By John Fox
The first therapeutic monoclonal antibody (MAb) that selectively targets activated intracellular cytosolic Ras mutant proteins, which are inaccessible to current antibodies, has been developed and assessed preclinically in a new South Korean study.
Read More

Study suggests new approach to fighting infections

May 15, 2017
By John Fox
An international study led by researchers at Monash University's Biomedicine Discovery Institute (BDI) in Melbourne has shown how the hepatitis C virus (HCV) takes over the communication systems in infected host cells, revealing potential new therapeutic targets for HCV and other diseases.
Read More

First lymphatic brain scavenger cells discovered

May 10, 2017
By John Fox

Australian scientists at the University of Queensland (UQ) have discovered a new type of lymphatic brain "scavenger" cell in zebrafish, which may provide protection from stroke and dementias such as Alzheimer's disease and have important implications for drug development.


Read More

First lymphatic brain scavenger cells discovered

May 9, 2017
By John Fox
Australian scientists at the University of Queensland (UQ) have discovered a new type of lymphatic brain "scavenger" cell in zebrafish, which may provide protection from stroke and dementias such as Alzheimer's disease and have important implications for drug development.
Read More

Molecular structure may hold key to neurodegenerative diseases

May 3, 2017
By John Fox
HONG KONG – Japanese researchers have determined for the first time the detailed atomic structure of a key molecule involved in intracellular transmission, which should contribute to development of better therapeutic approaches for neurodegenerative diseases such as Alzheimer's.
Read More

Antibody study may change TB vaccine design

May 3, 2017
By John Fox
The findings of a Chinese study showing that some health care workers exposed to high doses of the TB pathogen Mycobacterium tuberculosis (Mtb) made protective antibodies against future infection, despite having had no previous latent TB infection, may have important implications for rational development of new therapeutic and protective vaccines.
Read More

Antibody study may change TB vaccine design

May 2, 2017
By John Fox
The findings of a Chinese study showing that some health care workers exposed to high doses of the TB pathogen Mycobacterium tuberculosis (Mtb) made protective antibodies against future infection, despite having had no previous latent TB infection, may have important implications for rational development of new therapeutic and protective vaccines.
Read More
Previous 1 2 … 35 36 37 38 39 40 41 42 43 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2026.
  • CINP 2026: Prenatal and adolescent stress shape brain vulnerability

    BioWorld Science
    Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
  • Illustration of brain and brain waves, concept of focal seizure

    Hyperexcitability may be joint problem in epilepsy, dementia

    BioWorld
    The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • In the clinic for July 6, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing